212 related articles for article (PubMed ID: 641429)
21. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
Dutt A; Juneja HS
Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
[TBL] [Abstract][Full Text] [Related]
22. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
[TBL] [Abstract][Full Text] [Related]
23. Effects of bromocriptine on prolactin cellular hypertrophy, proliferation and secretory activity in diethylstilbestrol-induced pituitary tumors.
Phelps CJ; Hymer WC
Mol Cell Endocrinol; 1988 Aug; 58(2-3):137-48. PubMed ID: 3208992
[TBL] [Abstract][Full Text] [Related]
24. Haloperidol and oestrogens induce c-myc and c-fos expression in the anterior pituitary gland of the rat.
Cherñavsky AC; Valerani AV; Burdman JA
Neurol Res; 1993 Oct; 15(5):339-43. PubMed ID: 7905609
[TBL] [Abstract][Full Text] [Related]
25. Phorbol esters affect pituitary growth hormone (GH) and prolactin release: the interaction with GH releasing factor, somatostatin and bromocriptine.
Summers ST; Canonico PL; MacLeod RM; Rogol AD; Cronin MJ
Eur J Pharmacol; 1985 May; 111(3):371-6. PubMed ID: 2862049
[TBL] [Abstract][Full Text] [Related]
26. In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary glands: effects of ovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine and somatostatin.
Kacsóh B; Tóth BE; Avery LM; Grosvenor CE
Life Sci; 1993; 52(3):259-69. PubMed ID: 8093804
[TBL] [Abstract][Full Text] [Related]
27. Changes in the ultrastructural distribution of prolactin and growth hormone mRNAs in pituitary cells of female rats after estrogen and bromocriptine treatment, studied using in situ hybridization with biotinylated oligonucleotide probes.
Matsuno A; Ohsugi Y; Utsunomiya H; Takekoshi S; Sanno N; Osamura RY; Watanabe K; Teramoto A; Kirino T
Histochem Cell Biol; 1995 Jul; 104(1):37-45. PubMed ID: 7584558
[TBL] [Abstract][Full Text] [Related]
28. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
[TBL] [Abstract][Full Text] [Related]
29. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
Xu R; Parlow AF; Wang Y
Brain Res; 2002 Jun; 939(1-2):95-9. PubMed ID: 12020855
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of tamoxifen and bromocriptine on prolactin and pituitary weight in estradiol-treated male rats.
Lyle SF; Wright K; Collins DC
Cancer; 1984 Apr; 53(7):1473-7. PubMed ID: 6697292
[TBL] [Abstract][Full Text] [Related]
31. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of increased prolactin secretion by sulpiride.
MacLeod RM; Robyn C
J Endocrinol; 1977 Mar; 72(3):273-7. PubMed ID: 853259
[TBL] [Abstract][Full Text] [Related]
33. Effects of drugs infused into a rat hypophysial portal vessel on prolactin and growth hormone release.
Abe H; Kato Y; Chihara K; Iwasaki Y; Imura H
Proc Soc Exp Biol Med; 1980 Nov; 165(2):248-52. PubMed ID: 6160593
[No Abstract] [Full Text] [Related]
34. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Canonico PL; Valdenegro CA; MacLeod RM
Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
[TBL] [Abstract][Full Text] [Related]
35. Effects of growth hormone-releasing factor, somatostatin and dopamine on growth hormone and prolactin secretion from cultured ovine pituitary cells.
Law GJ; Ray KP; Wallis M
FEBS Lett; 1984 Jan; 166(1):189-93. PubMed ID: 6141070
[TBL] [Abstract][Full Text] [Related]
36. Effects of culture age on PRL and GH responses to bromocriptine and somatostatin from primary cultures of rat anterior pituitary cells.
Hanew K; Rennels EG
Proc Soc Exp Biol Med; 1982 Oct; 171(1):12-8. PubMed ID: 6128737
[No Abstract] [Full Text] [Related]
37. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of prolactin secretion and androgenic function in the adult male rat].
Jarrige JF; André M; Grizard G; Boucher D
C R Seances Soc Biol Fil; 1982; 176(4):517-24. PubMed ID: 6217871
[TBL] [Abstract][Full Text] [Related]
39. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
[TBL] [Abstract][Full Text] [Related]
40. Dopamine agonists both stimulate and inhibit prolactin release in GH4ZR7 cells.
Chang A; Shin SH
Eur J Endocrinol; 1999 Oct; 141(4):387-95. PubMed ID: 10526254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
